The interaction between impaired acute insulin response and insulin resistance predicts type 2 diabetes and impairment of fasting glucose

Upsala Journal of Medical Sciences

Volumn 113, Issue 2, 2008, Pages 117-130

  Zethelius, Björn ^a,b   Berglund, Lars ^a   Hänni, Arvo ^a   Berne, Christian ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55049132794     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-226     Document Type: Article

References (30)

1. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Waldenstrom J (1990) Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes. Diabet Med 7(5):407-13.
2. Mykkanen L, Kuusisto J, Pyorala K, Laakso M (1993) Cardiovascular disease risk factors as predictors of type 2 (non- insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36(6):553-9.
3. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329(27):1988-92.
4. Skarfors ET, Selinus KI, Lithell HO (1991) Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. Bmj 303(6805):755-60.
5. Ohlson LO, Larsson B, Bjorntorp P, Eriksson H, Svardsudd K, Welin L, Tibblin G, Wilhelmsen L (1998) Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31(11):798-805.
6. Stern MP, Morales PA, Valdez RA, Monterrosa A, Haffner SM, Mitchell BD, Hazuda HP (1993) Predicting diabetes. Moving beyond impaired glucose tolerance. Diabetes 42(5):706-14.
7. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ, Feskens EJ (1999) Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 22(2):213-9.
8. Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19(4):491-503.
9. Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24(1):89-94.
10. Kahn BB (1998) Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 92(5):593-6.
11. Haffner SM, Miettinen H, Gaskill SP, Stern MP (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44(12):1386-91.
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Diabetes Care 20(7):1183-97.
13. Hedstrand H (1975) A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Upsala J Med Sci 80 (Suppl.19):1-61.
14. Royston P (1991) Estimating departures from normality. Statistics in Medicine 10:1283-1293.
15. Allison DB, Paultre F, Goran MI, Poehlman ET, Heymsfield SB (1995) Statistical considerations regarding the use of ratios to adjust data. Int J Obes Relat Metab Disord 19(9):644-52.
16. DeFronzo RA, Tobin JD, Andres R (1993) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237(3):E214-23,1979
17. Laakso M (1993): How good a marker is insulin level for insulin resistance? Am J Epidemiol 137(9):959-65.
18. Phillips DI, Clark PM, Hales CN, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11(3):286-92.
19. Efron B (1982) The Jackknife, the Bootstrap and Other Resampling Plans. Regional Conference Series In Applied Mathematics; Philadelphia,Pennsylvania 19103, USA, Society of Industrial and Applied Mathematics.
20. Haenni A, Andersson PE, Lind L, Berne C, Lithell H (1994) Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups. Am J Hypertens 7(7 Pt 1):615-22.
21. Haffner SM, Miettinen H, Gaskill SP, Stern MP (1996) Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39(10):1201-7.
22. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al.(1993) Quantification of the relationship between insulin sensitivity and beta- cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42(11):1663-72.
23. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340(8825):925-9.
24. Byrne MM, Sturis J, Sobel RJ, Polonsky KS (1996) Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function. Am J Physiol 270(4 Pt 1):E572-9.
25. Wannamethee SG, Shaper AG, Whincup PH, Walker M (1999) Role of risk factors for major coronary heart disease events with increasing length of follow up. Heart 81(4):374-9.
26. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH (1991) A two-step model for development of non-insulin-dependent diabetes. Am J Med 90(2):229-35.
27. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343-50.
28. Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24(4):796-7.
29. Gerich J (2000) Adressing the Insulin Secretion Defect: A Logical First Line Approach. Metabolism 49 (10):12-16.
30. Szoke E, Gerich J (2005) Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Comprehensive Therapy 31 (2): 106-112.